Real-world clinical and patient-reported outcomes of talimogene laherparepvec (T-VEC) treatment for melanoma in transit and nodal metastases at a UK centre

The requested reference [c5c0e30152fcbf19fd255d59b76951e9c509f5f7] no longer exists in our database. It has been replaced by the current reference: [d113f34e5185113433e6b90c3841312609506add]

Authors
Category Primary study
JournalBritish Journal of Dermatology
Year 2023
This article has no abstract
Epistemonikos ID: 994a532f0b2670b209a796e6d5db7e36394bdae3
First added on: Dec 07, 2023